Patent 10953093 was granted and assigned to University College Cork on March, 2021 by the United States Patent and Trademark Office.
The present invention relates to a method for the treatment of cancer in a subject which comprises the steps of: (i) administering electroporation to a tumour in the subject; and (II) administering a T or B-cell activiating agent to the subject, wherein step (i) and (II) may be performed in either order.